Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -126.99% is 73% below its 5-year average of -73.49%, near the low end of its 5-year range (-131.11%–-31.29%).
As of the fiscal period ended Friday, July 31, 2026. 10.36% below its 12-month average of -115.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-07-31): -126.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-126.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-115.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-86.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-73.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-77.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.36%
CURRENT VS 3Y AVG
-46.68%
CURRENT VS 5Y AVG
-72.82%
CURRENT VS 10Y AVG
-64.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-256.13%
vs the sector median at left
Nutriband Inc.
Market Cap
$81.20M
Return on Invested Capital (ROIC)
-126.99%
TTM Avg
-115.07%
3Y Avg
-86.58%
5Y Avg
-73.49%
Market Cap
$81.22M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$80.30M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$82.29M
Return on Invested Capital (ROIC)
-16.28%
TTM Avg
-50.22%
3Y Avg
-41.74%
5Y Avg
-37.86%
Market Cap
$82.47M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$82.53M
Return on Invested Capital (ROIC)
-120.93%
TTM Avg
-913.64%
3Y Avg
-646.22%
5Y Avg
-579.89%
Market Cap
$82.59M
Return on Invested Capital (ROIC)
-87.79%
TTM Avg
-271.72%
3Y Avg
-628154.34%
5Y Avg
-503132.91%
Market Cap
$79.61M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$79.03M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $81.20M | -126.99% | -115.07% | -86.58% | -73.49% |
| MediciNova, Inc. (MNOV)vs › | $81.22M | -31.62% | -27.86% | -23.01% | -20.58% |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -90.27% | -103.33% | -85.38% | -72.83% |
| LENSAR Inc (LNSR)vs › | $82.29M | -16.28% | -50.22% | -41.74% | -37.86% |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -159.30% | -82.85% | -66.58% | -50.22% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | -120.93% | -913.64% | -646.22% | -579.89% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | -87.79% | -271.72% | -628154.34% | -503132.91% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | -88.28% | -61.59% | -48.92% | -67.61% |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -88.72% | -42.77% | -39.33% | -39.33% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -11.48% | -56.27% | -1130.61% | -797.97% |
ROIC
-127.0%
ROE
-130.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -126.99% |
| 2026-04-30 | -131.11% |
| 2026-01-31 | -120.68% |
| 2025-10-31 | -118.63% |
| 2025-07-31 | -77.95% |
| 2025-04-30 | -115.39% |
| 2025-01-31 | -101.14% |
| 2024-10-31 | -52.77% |
| 2024-07-31 | -49.93% |
| 2024-04-30 | -41.35% |
| 2024-01-31 | -73.31% |
| 2023-10-31 | -65.90% |
| 2023-07-31 | -50.38% |
| 2023-04-30 | -60.76% |
| 2023-01-31 | -51.28% |
| 2022-10-31 | -66.33% |
| 2022-07-31 | -66.35% |
| 2022-04-30 | -57.44% |
| 2022-01-31 | -51.03% |
| 2021-10-31 | -31.29% |
| 2021-07-31 | -33.19% |
| 2021-04-30 | -28.81% |
| 2021-01-31 | -29.25% |
| 2020-10-31 | -11.29% |
| 2020-07-31 | -91.91% |
| 2020-04-30 | -104.22% |
| 2020-01-31 | -404.40% |
| 2019-10-31 | -146.23% |
| 2019-07-31 | -117.64% |
| 2019-04-30 | -162.75% |
| 2019-01-31 | -136.27% |
| 2018-10-31 | -111.82% |
| 2018-07-31 | -80.37% |
| 2018-04-30 | -1731.23% |
| 2018-01-31 | -112.71% |
| 2017-10-31 | -11.20% |
| 2017-07-31 | -7.68% |
| 2017-01-31 | -450.48% |
